Six-week treatment with hexarelin in young dogs: Evaluation of the GH responsiveness to acute hexarelin or GHRH administration, and of the orexigenic effect of hexarelin

European Journal of Endocrinology

Volumn 141, Issue 3, 1999, Pages 313-320

  Rigamonti, Antonello E ^a   Cella, Silvano G ^a   Marazzi, Nicoletta ^a   Müller, Eugenio E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HEXARELIN; SOMATOSTATIN;

ANIMAL EXPERIMENT; APPETITE; ARTICLE; CONTROLLED STUDY; DOG; DOWN REGULATION; FEEDING BEHAVIOR; FEMALE; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE RESPONSE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AREA UNDER CURVE; DOGS; EATING; FEMALE; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; GROWTH SUBSTANCES; HYDROCORTISONE; INFUSIONS, INTRAVENOUS; INSULIN-LIKE GROWTH FACTOR I; MALE; OLIGOPEPTIDES; RADIOIMMUNOASSAY; RANDOM ALLOCATION; SOMATOSTATIN;

EID: 0032831698     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1410313     Document Type: Article

References (45)

1. Locatelli V & Torsello A. Growth hormone secretagogues: focus on the growth hormone-releasing peptides. Pharmacological Research 1997 36 415-423.
2. Cella SG, Locatelli V, Poratelli M, De Gennaro Colonna V, Imbimbo BP, Deghenghi R et al. HEXA, a potent GHRP analogue: interactions with GHRH and clonidine in young and aged dogs. Peptides 1995 16 81-86.
3. Deghenghi R, Boutignon F, Luoni M, Grilli R, Guidi M & Locatelli V. Small peptides as potent releasers of growth hormone. Journal of Pediatric Endocrinology and Metabolism 1995 8 311-313.
4. Smith RG, Cheng K, Schoen WR, Pong S-S, Hickey G, Jacks T et al. A non-peptidyl growth hormone secretagogue. Science 1993 260 1640-1643.
5. Ilson BE, Jorkasky DK, Curnow RT & Stote RM. Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. Journal of Clinical Endocrinology and Metabolism 1989 69 212-214.
6. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS & Thorner MO. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. Journal of Clinical Endocrinology and Metabolism 1990 70 975-982.
7. Gertz BJ, Barrett JS, Eisenhandler R, Krupa DA, Wittreich JM, Seibold JR et al. Growth hormone response in man to L-692, 429, a novel nonpeptide mimic of growth hormone releasing peptide-6. Journal of Clinical Endocrinology and Metabolism 1993 77 1393-1397.
8. Arvat E, Gianotti L, Di Vito L, Imbimbo BP, Lenaerts V, Deghenghi R et al. Modulation of growth hormone-releasing activity of HEXA in man. Neuroendocrinology 1995 61 51-56.
9. Chapman IM, Bach MA, van Cauter E, Farmer M, Krupa D, Taylor AM et al. Stimulation of the growth hormone (GH)-insulin-like growth factor axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects. Journal of Clinical Endocrinology and Metabolism 1996 81 4249-4257.
10. Jacks T, Hickey G & Judith F. Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-I, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles. Journal of Endocrinology 1994 143 399-406.
11. Copinschi G, van Onderbergen A, l'Hermite-Baleriaux M, Mendel CM, Caufriez A, Leproult R et al. Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-h GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men. Journal of Clinical Endocrinology and Metabolism 1996 81 2776-2782.
12. Arvat E, Maccagno B, Ramunni J, Di Vito L, Broglio F, Deghenghi R et al. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans. Neuroendocrinology 1997 66 432-438.
13. Locke W, Kirgis HD, Bowers CY & Abdoh AA. Intracerebroventricular growth hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in rats. Life Science 1995 56 1347-1352.
14. Okada K, Ishii S, Minami S, Shibasaki T & Wakabayashi I. Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats. Endocrinology 1996 137 5155-5158.
15. Torsello A, Luoni M, Schweiger F, Grilli R, Guidi M, Bresciani E et al. Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release. European Journal of Pharmacology 1998 360 123-129.
16. Frieboes RM, Murck H, Maier P, Schier T, Holsboer F & Steiger A. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology 1995 61 584-589.
17. Moreno Reyes R, Kerkhofs M, l'Hermite Baleriaux M, Thorner MO, Van Cauter E & Copinschi G. Evidence against a role for the growth hormone-releasing peptide axis in human slow-wave sleep regulation. American Journal of Physiology 1998 274 E779-E784.
18. Cella SG, Cerri CG, Daniel S, Sibilia V, Rigamonti A, Cattaneo L et al. Sixteen weeks of hexarelin therapy in aged dogs: effect on the somatotropic axis, muscle morphology, and bone metabolism. Journal of Gerontology 1996 51A B439-B447.
19. Clark RG, Carlsson LMS, Trojnar J & Robinson ICAF. The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthetized rats. Journal of Neuroendocrinology 1989 1 249-255.
20. Guillaume V, Magnan E, Cataldi M, Dutour A, Sauze N, Renard M et al. GH-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 1994 135 1073-1076.
21. Dickson SL, Leng G, Dyball REJ & Smith RG. Central action of peptide and non-peptide growth hormone secretagogues in the rat. Neuroendocrinology 1995 61 36-43.
22. Cella SG, Luceri M, Cattaneo L & Müller EE. Somatostatin withdrawal as generator of pulsatile GH release in the dog: a possible tool to evaluate the endogenous GHRH tone? Neuroendocrinology 1996 63 481-488.
23. Degli Uberti EC, Ambrosio MR, Cella SG, Margutti AR, Trasforini G. Rigamonti AE et al. Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man. Journal of Clinical Endocrinology and Metabolism 1997 82 2885-2888.
24. Magnan E, Cataldi M, Guillaume V, Conte-Devolx B, Graziani N, Figaroli JC et al. Acute changes in growth hormone-releasing hormone secretion after injection of BIM 23014, a long acting somatostatin analog, in rams. Life Science 1992 51 831-838.
25. Clark RG, Thomas GB, Mortensen DL, Won WB, Ma YH, Tomlinson EE et al. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat. Endocrinology 1997 138 4316-4323.
26. Daugaday WH, Kapadia M & Mariz I. Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay. Journal of Laboratory and Clinical Medicine 1987 109 355-363.
27. Rahim A, O'Neill PA & Shalet SM. Growth hormone status during long-term hexarelin therapy. Journal of Clinical Endocrinology and Metabolism 1998 83 1644-1649.
28. Argente J, Garcia-Segura LM, Pozo J & Chowen JA. Growth hormone-releasing peptides: clinical and basic aspects. Hormone Research 1996 46 155-159.
29. Dickson S, Macdonald LP, Bailey ART & Leng G. Retrograde labelling of GHRP-6-responsive cells in the rat arcuate nucleus which project to the paraventricular nucleus (PVN) of the hypothalamus. In Book of Abstracts of the 80th Annual Meeting of the Endocrine Society, June 24-27 1998, New Orleans. Abstract OR09-5, p. 64.
30. Arvat E, Di Vito L, Gianotti L, Ramunni J, Boghen M, Deghenghi R et al. Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man. Metabolism 1997 46 83-88.
31. Bennett PA, Thomas GB, Howard AD, Feighner SD, van der Ploeg LH, Smith RG et al. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology 1997 138 4552-4557.
32. Berelowitz M, Szabo LA, Firestone S, Chu L & Hintz RL. Somatomedin C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 1981 212 1279-1281.
33. Ceda GP. IGFs in the feedback control of GH secretion: hypothalamic and/or pituitary action? Journal of Endocrinological Investigation 1995 18 734-737.
34. Lieber RL, Jacks TM, Mohler RL, Schleim K, Haven M, Cuizon D et al. Growth hormone secretagogue increases muscle strength during remobilization after canine hindlimb immobilization. Journal of Orthopaedic Research 1997 15 519-527.
35. Locatelli V, Grilli R, Torsello A, Cella SG, Wehrenberg WB & Müller EE. Growth hormone releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat. Pediatric Research 1994 36 169-174.
36. Torsello A, Luoni M, Grilli R, Guidi M, Wehrenberg WB, Deghenghi R et al. Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult rat model of impaired GHRH function. Neuroendocrinology 1997 65 91-97.
37. Klinger B, Silbergeld A, Deghenghi R, Frenkel J & Laron Z. Desensitization from long term intranasal treatment with hexarelin does not interfere with the biological effects of this growth hormone-releasing peptide in short children. European Journal of Endocrinology 1996 134 716-719.
38. Ghigo E, Arvat E, Gianotti L, Grottoli S, Rizzi G, Ceda GP et al. Short-term administration of intranasal or oral hexarelin, a synthetic hexapeptide, does not desensitize the growth hormone responsiveness in human aging. European Journal of Endocrinology 1996 135 407-412.
39. Ghigo E, Arval E, Gianotti L, Imbimbo BP, Lenaerts V, Deghenghi R et al. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. Journal of Clinical Endocrinology and Metabolism 1994 78 693-698.
40. Bennett PA, Thomas GB & Robinson ICAF. Growth hormone-releasing peptide (GHRP-6) regulation of hypothalamic gene expression. In Book of Abstracts of the 80th Annual Meeting of the Endocrine Society, June 24-27 1998, New Orleans. Abstract P2-225, p. 299.
41. Morley JE. Neuropeptide regulation of appetite and weight. Endocrine Review 1987 8 256-287.
42. Inui A, Okita M, Nakajima M, Inoue T, Sakatani N, Oya M et al. Neuropeptide regulation of feeding in dogs. American Journal of Physiology 1991 261 R588-R594.
43. Hansen BS, Hansen A, Vissing H & Andersen PH. Growth hormone secretagogue receptor subtypes? In Book of Abstracts of the 80th Annual Meeting of the Endocrine Society, June 24-27 1998, New Orleans. Abstract P2-220, p. 298.
44. Muccioli G, Ghe C, Ghigo MC, Papotti M, Arvat E, Boghen M et al. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. Journal of Endocrinology 1998 157 99-106.
45. Ong H, McNicoll N, Escher E, Collu R, Deghenghi R, Locatelli V et al. Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labeling. Endocrinology 1998 139 432-435.